Rain Therapeutics Clinical Trials
A clinical trial is a controlled study where an experimental drug or device is tested in humans. The purpose of a clinical trial is to evaluate the safety and efficacy (how well it works) of an experimental drug or device. To participate in a clinical trial, you must meet all eligibility criteria and be willing to following the directions of the study doctor.
Rain is currently conducting a Phase 2 clinical trial studying its drug, tarloxotinib (Tarlox), in non-small cell lung cancer (NSCLC) patients with EGFR Exon 20 or HER2 activating mutations. To learn more about NSCLC, EGFR and HER2 mutations, Tarlox and details about the clinical trial, continue reading below. If you have any additional questions, you can contact the study center in your area.